Special Interview: Tasuku Honjo X Uğur Şahin

Tasuku Honjo talks to Biontech founder Uğur Şahin about the surprising history of major breakthroughs in medical innovation, from cancer immunotherapy to COVID vaccines.

More

Paper: Rejuvenation of aged immune cells improves PD-1 blockade cancer immunotherapy

Although aging is known to suppress antitumor immunity, the precise underlying mechanism remains largely unknown. A new paper now explains why aging may be relevant to cancer immunity and immunotherapy.

More

UBC honorary degree for Professor Tasuku Honjo

CCII Founding Director Tasuku Honjo is awarded a honorary degree by the University of British Columbia, Canada.

More

Cancer Immunotherapy Research Fund launched

Kyoto University established a new research fund to support research in cancer immunotherapy.

More

[CLOSED] Call for Applications: Associate Professor Position within the Metabolome Platform Team

This Call for Applications is now closed, but we are permanently recruiting. Please contact us!

More